How COVID|19 is reshaping China's medtech industry

How COVID-19 is reshaping China's medtech industry | McKinsey

China's medtech distributors have been the target of many rounds of policies, since their margins are seen as a key factor in making medical ...

How COVID-19 is reshaping China's medtech industry - LinkedIn

The global COVID-19 outbreak is firstly a humanitarian challenge, but it is also having a marked and growing impact on the world economy.

China's medtech market set to grow vigorously despite headwinds

The key drivers of growth in China's medical devices market include the country's ageing population and an increasing number of chronic conditions.

Does China's Leading Place in the Global Medtech Market Reflect ...

Highlighting the innovators and entrepreneurs who are shaping the future of medical technology. ... Since the Covid pandemic, China's ...

Yvonne (Yingyue) Xu on LinkedIn: How COVID-19 is reshaping ...

With COVID-19 accelerating the underlying trends in China's medtech industry, new business models are likely to emerge.

How COVID-19 Is Reshaping China's Medtech Industry ...

How COVID-19 Is Reshaping China's Medtech Industry. May 6, 2020. 12 minute read. 4 Views. Summary. With COVID-19 accelerating the underlying trends in China's ...

Looking at the impact of COVID-19 on the economy & the MedTech ...

Looking at the impact of COVID-19 on the economy & the MedTech industry in China ... Change in volume of use of selected low- and high- value consumables.

Insights into Chinese Medical Device Companies Going Global

“The core of 'Made in China' is changing along with the trend of Chinese enterprises going global,” he says. “It now holds a different meaning ...

The govt is reshaping China's medical technology industry

The pandemic also increased the role of online medical services. Given the potential benefits of digital healthcare, the Chinese government has ...

The rise of Asian corporations - McKinsey & Company

How COVID-19 is reshaping China's medtech industry. Article. How COVID-19 is reshaping China's medtech industry · Lessons from Asian banks on ...

How the Coronavirus Will Transform Healthcare in China

CROs and CDMOs will have more buy-in from the government, pharma and medtech companies, and medical facilities. With additional support for R&D, ...

Coping with COVID: Performance of China's hierarchical medical ...

We suggest improving the service capacity of primary hospitals and changing the preferences of patients through health education in the post- ...

China's Public Procurement Protectionism and Europe's Response

This is also clear in trade data: Chinese exports of medical devices have taken an extraordinary jump during the Covid-19 pandemic, and China's MedTech industry ...

Medtech: The Pandemic Has Expanded Needs and Opportunities

As the Asia-Pacific private equity market continues to mature, medtech activity has surged, particularly in China, fueled by governmental ...

Global medtech industry resets to pre-pandemic norms as ... - EY

“Once the macro environment stabilizes, the breakthrough AI and digital technologies have the potential to dramatically revitalize and reshape ...

China Healthcare Tech Insight: Trends, Risks, and Opportunities

China's post-pandemic medtech market: A mix of upsides and downsides. China's COVID-19 policy went through some extraordinary developments in 2022. In ...

COVID-19 Continues to Impact Medical Device Manufacturing in ...

In China alone, where the virus was first detected, many medical device companies ... Covid-19 diagnostics – but this will change. 10 March ...

COVID and the U.S.-China Medtech Relationship

... industry leaders shaping the future of medical devices. View all · ODT ... 19 emergency response and the years of steady U.S. investments into ...

China healthcare tech insight: trends, risks, and opportunities

COVID-19 boosted the growth of Chinese medtech companies. Soaring demand from overseas markets for COVID-19-related medical devices—such as ...

Chinese Medical Device Industry: How to thrive in an increasingly ...

The whitepaper examines how foreign brands can enter the Chinese market by adopting an "In China, For China" strategy amid a changing regulatory environment.